Agentic data science with the Data Agent Kit
cloud.google.com·7h ago
AI Research
arXiv CS.AI·10d ago·5 min read
SCOPE-AD: Sequential cost-aware ordinal-belief planning with energy-based models for diagnostic agents
TL;DR
SCOPE-AD is a novel approach for diagnosing Alzheimer's disease that integrates cost-aware decision-making with energy-based models. It achieves a Macro-F1 score of 77.70% while minimizing acquisition costs, outperforming existing methods significantly.
✦ Why It Matters
Implement SCOPE-AD to enhance diagnostic accuracy while managing costs in Alzheimer's disease assessments.
Key Takeaways
- Utilize SCOPE-AD for cost-effective Alzheimer's diagnosis.
- Implement mask-aware ordinal models to handle uncertainty.
- Leverage retrospective training records for better decision-making.
- Focus on selective acquisition to minimize testing costs.
How It Works
SCOPE-AD employs a mask-aware ordinal model to represent uncertainty in diagnosing Alzheimer's disease. It uses energy-based models to create a Qwen policy that guides the agent in selecting tests based on cost and available evidence.
The agent updates its beliefs after each test acquisition, allowing for dynamic decision-making that balances cost and diagnostic accuracy.